PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Pneumococcal vaccine reduces antibiotic-resistant infections in children by 62 percent

Important tool in combating superbugs

2014-10-10
(Press-News.org) PHILADELPHIA –The pneumococcal vaccine recommended for young children not only prevents illness and death, but also has dramatically reduced severe antibiotic-resistant infections, suggests nationwide research being presented at IDWeek 2014™. Pneumococcal infection – which can cause everything from ear infections to pneumonia and meningitis – is the most common vaccine-preventable bacterial cause of death.

The 13-valent pneumococcal conjugate vaccine (PCV13), first available in 2010 (replacing 7-valent pneumococcal conjugate vaccine, PCV7), reduced the incidence of antibiotic-resistant invasive pneumococcal disease by 62 percent from 2009 to 2013 among children under five years old. The study is the first report of the effectiveness of PCV13 to combat antibiotic-resistant infections, a vaccination recommended for children under five years old. Three-quarters of states require it for entry into daycare, and 85 percent of U.S. children have received the recommended four doses.

"We're at risk of living in a post-antibiotic world, where these miracle medications no longer work, but this vaccine is part of the solution to protecting ourselves from the growing threat of antibiotic resistance," said lead researcher Sara Tomczyk, PHN, MSc, epidemic intelligence service (EIS) officer for the Respiratory Diseases Branch, Centers for Disease Control and Prevention (CDC), Atlanta. "Not only does this vaccine prevent pneumococcal infection, which means fewer antibiotics are prescribed, but it also prevents antibiotic-resistant infections."

The U.S. government's Healthy People 2020 initiative set a goal of reduction of antimicrobial-resistant invasive pneumococcal disease from 9.3 to 6 cases per 100,000 children. In the course of analyzing the data for this study, the team realized the goal had been met nine years early due to the effectiveness of the pneumococcal vaccine. Currently, the rate is 3.5 cases per 100,000 children.

PCV13 is given to children in four doses, at two, four, six and 12 through 15 months of age. The study collected data representing approximately 10 percent of the United States, which is considered illustrative of the country as a whole, said Tomczyk. PCV13 is effective against 13 strains of pneumococcal bacteria, while PCV7 was effective against seven. One dose of PCV13 also is now recommended for all adults 65 and older, followed by a dose of the pneumococcal polysaccharide vaccine (PPSV23) six to 12 months later. Additionally, one dose of PCV13 is recommended for adults 19 and older with certain cancers, HIV and kidney failure, followed by doses of PPSV23.

INFORMATION:

AT A GLANCE - The pneumococcal conjugate vaccine (PCV13) significantly reduced serious infections, including those caused by antibiotic-resistant superbugs, according to the first research on the vaccine.

- Since the vaccine was introduced in 2010, the incidence of antibiotic-resistant invasive pneumococcal disease decreased by 62 percent among children under five years old.

- The vaccine is so effective the Healthy People 2020 goal of reducing antimicrobial-resistant invasive pneumococcal disease from 9.3 to 6 cases per 100,000 children was met nine years early and has since dropped to 3.5 cases.

- PCV13 prevents serious illness, such as pneumonia, meningitis and blood stream infections. The vaccine is recommended for all children five and younger.

About IDWeek IDWeek 2014TM is the annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA) and the Pediatric Infectious Diseases Society (PIDS). With the theme "Advancing Science, Improving Care," IDWeek features the latest science and bench-to-bedside approaches in prevention, diagnosis, treatment, and epidemiology of infectious diseases, including HIV, across the lifespan. IDWeek 2014 takes place October 8-12 at the Pennsylvania Convention Center in Philadelphia. For more information, visit http://www.idweek.org.



ELSE PRESS RELEASES FROM THIS DATE:

Real-life social networking prompts people to get tested for HIV

2014-10-10
PHILADELPHIA – Old-school face-to-face social networking is a more effective way to identify people with HIV than the traditional referral method, suggests research being presented at IDWeek 2014™. The study shows that social networking strategies (SNS) – enlisting people in high-risk groups to recruit their peers to get tested – is more efficient and targeted than traditional testing and referral programs, resulting in 2-1/2 times more positive test results. As many as 20 percent of HIV-positive people are unaware of being infected with the virus, ...

Rare 'baby rattle' molecules reveal new quantum properties of H2O and H2

2014-10-10
The experiments were carried out on endofullerenes, molecules of C60 into which smaller molecules of Hydrogen (H2) had been inserted. The results, published in Physical Review Letters, represent the first known example of a quantum selection rule found in a molecule. Similar techniques were also used by the same team to uncover an exciting new symmetry-breaking interaction of water molecules with C60 cages, published last month in Physical Chemistry Chemical Physics. The use of fullerenes such as C60 to trap smaller molecules, using cutting-edge molecular surgery techniques, ...

Old textbook knowledge reconfirmed: Decay rates of radioactive substances are constant

Old textbook knowledge reconfirmed: Decay rates of radioactive substances are constant
2014-10-10
This news release is available in German. The distance between the Earth and the Sun has no influence on the decay rate of radioactive chlorine. You could ask: "And why should it anyway?", because it is well known that the decay of radionuclides is as reliable as a Swiss clock. Recently, US-American scientists, however, attracted attention when they postulated that the decay rate depends on the flow of solar neutrinos and, thus, also on the distance from the Earth to the Sun. Their assumption was based, among other things, on older measurement data of the Physikalisch-Technische ...

Mineralization of sand particles boosts microbial water filtration

2014-10-10
WASHINGTON, DC – OCTOBER 10, 2014 - Mineral coatings on sand particles actually encourage microbial activity in the rapid sand filters that are used to treat groundwater for drinking, according to a paper published ahead of print in Applied and Environmental Microbiology. These findings resoundingly refute, for the first time, the conventional wisdom that the mineral deposits interfere with microbial colonization of the sand particles. "We find an overwhelmingly positive effect of mineral deposits on microbial activity and density," says corresponding author Barth ...

Dangerous blood clots: A serious global problem

2014-10-10
A study on the global burden of venous thromboembolism—when a dangerous clot forms in a blood vessel—found that annual incidences range from 0.75 to 2.69 per 1,000 individuals in the population. The incidence increased to between 2 and 7 per 1,000 among those 70 years of age or more. "Venous thromboembolism in hospitalized patients was responsible for more years lost due to ill-health than hospital-acquired pneumonia, catheter-related blood stream infections, and side effects from drugs," said Dr. Gary Raskob, co-author of the Journal of Thrombosis & Haemostasis ...

Researchers find RNA molecules in urine and tissue that detect prostate cancer

2014-10-10
Philadelphia, PA, October 9, 2014 – Researchers at Sanford-Burnham Medical Research Institute have identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients but not in normal healthy individuals. The study sets the stage for the development of more sensitive and specific noninvasive tests for prostate cancer than those currently available, which could result in fewer unnecessary prostate biopsies with less treatment-related morbidity, according to a new study in The Journal of Molecular Diagnostics. According to ...

Stanford team invents sensor that uses radio waves to detect subtle changes in pressure

Stanford team invents sensor that uses radio waves to detect subtle changes in pressure
2014-10-10
Stanford engineers have invented a wireless pressure sensor that has already been used to measure brain pressure in lab mice with brain injuries. The underlying technology has such broad potential that it could one day be used to create skin-like materials that can sense pressure, leading to prosthetic devices with the electronic equivalent of a sense of touch. A nine-member research team led by Chemical Engineering Professor Zhenan Bao detailed two medical applications of this technology in Nature Communications. In one simple demonstration they used this wireless ...

Similar but different: New discovery for degenerative disease

2014-10-10
Researchers from the University of Melbourne have established how two diseases that present in similar ways are in fact quite different. Progressive Supranuclear palsy and Parkinson's Disease have overlapping symptoms but remain difficult to distinguish. However, a first ever paper on the topic published in the Journal of Neuropsychology (British Psychological Society publication) now suggests that people with PSP experience more severe and extensive cognitive impairments than those with PD early on. The study indicates that patients with PSP experience more severe ...

Longer-term outcomes of program to reduce unnecessary antibiotic prescriptions

2014-10-10
The initial benefits of an outpatient antimicrobial stewardship intervention designed to reduce the rate of inappropriate antibiotic prescriptions were lost after discontinuation of audit and feedback to clinicians, according to a study published in JAMA. The study is being released early online to coincide with the IDWeek 2014 meeting. Antibiotics are the most frequently prescribed medications for children; most are prescribed for outpatient acute respiratory tract infections. Because antibiotic prescribing is often inappropriate, Jeffrey S. Gerber, M.D., Ph.D., of ...

An unexpected bonus

An unexpected bonus
2014-10-10
The so-called Signal Transducers and Activators of Transcription, or STATs, are key components of many different signalling pathways. Not surprisingly, then, when something goes wrong with their regulation the consequences can be severe and many types of cancer are known to be associated with increased activities of one or more STAT protein. STAT3 is a frequent culprit and is often found to be activated in tumour cells. Considerable efforts are going into developing inhibitors of STAT3 for use in cancer therapy but it is unclear whether these will turn out to be suitable ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Pneumococcal vaccine reduces antibiotic-resistant infections in children by 62 percent
Important tool in combating superbugs